Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Jan 08, 2024

SELL
$2.98 - $14.09 $894,000 - $4.23 Million
-300,000 Closed
0 $0
Q3 2019

Jan 08, 2024

SELL
$2.05 - $3.02 $1.43 Million - $2.11 Million
-700,000 Reduced 70.0%
300,000 $6.15 Million
Q2 2019

Jan 08, 2024

BUY
$2.29 - $4.1 $2.29 Million - $4.1 Million
1,000,000 New
1,000,000 $8.82 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $524M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.